I agree that this site is using cookies. You can find further informations here.
X
Mariot, V.
87  results:
Search for persons X
?
1

VP.61 An AAV-shRNA DUX4-based therapy to treat facioscapulo..:

Mariot, V. ; Sidlauskaite, E. ; Gall, L. Le..
Neuromuscular Disorders.  32 (2022)  - p. S107 , 2022
Link: https://doi.org/10.1016/..
 
?
2

FP.11 Impact of disease-modifying therapies on myostatin le..:

Mackels, L. ; Mariot, V. ; Servais, L..
Neuromuscular Disorders.  32 (2022)  - p. S58 , 2022
Link: https://doi.org/10.1016/..
 
?
3

NEW INSIGHTS INTO CELLULAR FUNCTIONS:

Gall, I. Le ; Lucas, O. ; Roquevière, S....
Neuromuscular Disorders.  28 (2018)  - p. S89 , 2018
Link: https://doi.org/10.1016/..
 
?
4

NEW THERAPEUTIC APPROACHES AND THEIR READOUT:

Dumonceaux, J. ; Mariot, V. ; Le Guiner, C....
Neuromuscular Disorders.  28 (2018)  - p. S91 , 2018
Link: https://doi.org/10.1016/..
 
?
5

Myostatin is a reliable biomarker for monitoring drug respo..:

Mariot, V. ; Le Guiner, C. ; Inès, B....
Neuromuscular Disorders.  28 (2018)  - p. S19 , 2018
Link: https://doi.org/10.1016/..
 
?
6

Myostatin expression in neuromuscular diseases:

Mariot, V. ; Le Guiner, C. ; Inès, B....
Neuromuscular Disorders.  28 (2018)  - p. S2 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Reversible endogenous downregulation of myostatin pathway i..:

Mariot, V. ; Joubert, R. ; Hourdé, C....
Neuromuscular Disorders.  27 (2017)  - p. S97-S98 , 2017
Link: https://doi.org/10.1016/..
 
?
8

Myostatin inhibition for neuromuscular disorders: defining ..:

Mariot, V. ; Joubert, R. ; Hourdé, C....
Neuromuscular Disorders.  27 (2017)  - p. S8 , 2017
Link: https://doi.org/10.1016/..
 
?
9

Myostatin expression levels in neuromuscular diseases parti..:

Mariot, V. ; Joubert, R. ; Hourdé, C....
Neuromuscular Disorders.  27 (2017)  - p. S231 , 2017
Link: https://doi.org/10.1016/..
 
?
10

Correlation between low FAT1 expression and early affected ..:

Mariot, V. ; Roche, S. ; Hourdé, C....
Neuromuscular Disorders.  25 (2015)  - p. S312 , 2015
Link: https://doi.org/10.1016/..
 
?
11

P-233 Promoter methylation abrogates of NFκB-mediated FAS g..:

Ettou, S. ; Humbrecht, C. ; Benet, B....
Leukemia Research.  37 (2013)  - p. S128 , 2013
Link: https://doi.org/10.1016/..
 
?
12

P.16.3 DUX4 and DUX4 downstream target genes are expressed ..:

Ferreboeuf, M. ; Mariot, V. ; Bessières, B....
Neuromuscular Disorders.  23 (2013)  9-10 - p. 823 , 2013
Link: https://doi.org/10.1016/..
 
?
13

239 NF-κB regulates FAS gene expression in myelodysplastic ..:

Ettou, S. ; Humbrecht, C. ; Benet, B....
Leukemia Research.  35 (2011)  - p. S94 , 2011
Link: https://doi.org/10.1016/..
 
?
14

Chitosan-Shelled Nanobubbles Irreversibly Encapsulate Morph..:

Falzarano, MS ; Argenziano, M ; Marsollier, AC...
info:eu-repo/semantics/altIdentifier/pmid/32679000.  , 2021
Link: http://hdl.handle.net/23..
 
?
15

RIPK3-mediated cell death is involved in DUX4-mediated toxi..:

Mariot, V ; Joubert, R ; Le Gall, L...
https://discovery.ucl.ac.uk/id/eprint/10137222/1/jcsm.12813.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
1-15